Britain has approved Pfizer’s COVID-19 pill for adults who have mild to moderate infection and are at high risk of…
Browsing: Health
Sinovac’s two-dose COVID-19 vaccine followed by a booster Pfizer-BioNTech shot showed a lower immune response against the Omicron variant compared…
SYDNEY: The world began ushering in 2022 on Friday after another tumultuous and pandemic-ridden year capped by new restrictions, soaring…
